Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Afya Ltd (AFYA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/07/2025: AFYA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -56.52% | Avg. Invested days 23 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/07/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.61B USD | Price to earnings Ratio 14.94 | 1Y Target Price 19.32 |
Price to earnings Ratio 14.94 | 1Y Target Price 19.32 | ||
Volume (30-day avg) 105279 | Beta 0.82 | 52 Weeks Range 14.33 - 19.80 | Updated Date 03/31/2025 |
52 Weeks Range 14.33 - 19.80 | Updated Date 03/31/2025 | ||
Dividends yield (FY) 1.29% | Basic EPS (TTM) 1.2 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 19.11% | Operating Margin (TTM) 30.31% |
Management Effectiveness
Return on Assets (TTM) 7.72% | Return on Equity (TTM) 16.32% |
Valuation
Trailing PE 14.94 | Forward PE 11.34 | Enterprise Value 2010095700 | Price to Sales(TTM) 0.49 |
Enterprise Value 2010095700 | Price to Sales(TTM) 0.49 | ||
Enterprise Value to Revenue 3.51 | Enterprise Value to EBITDA 7.89 | Shares Outstanding 46464500 | Shares Floating 9742549 |
Shares Outstanding 46464500 | Shares Floating 9742549 | ||
Percent Insiders 76.98 | Percent Institutions 31.81 |
Analyst Ratings
Rating 3.33 | Target Price 19.99 | Buy 2 | Strong Buy 1 |
Buy 2 | Strong Buy 1 | ||
Hold 5 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Afya Ltd
Company Overview
History and Background
Afya Ltd. was founded in 2019. It is a medical education group in Brazil, offering undergraduate and graduate programs in medicine and other healthcare fields.
Core Business Areas
- Undergraduate Medical Education: Offers undergraduate medical education programs across its campuses in Brazil.
- Continuing Medical Education: Provides continuing medical education programs for physicians and healthcare professionals.
- Digital Services: Offers digital services, including medical content, online courses, and other technology-driven solutions for healthcare professionals and students.
Leadership and Structure
The leadership team consists of experienced executives in the education and healthcare sectors. The organizational structure includes executive management, operational divisions for each business segment, and corporate support functions.
Top Products and Market Share
Key Offerings
- Undergraduate Medical Education: Afya's core offering is its undergraduate medical education programs, which contribute significantly to its revenue. The market share in Brazil's private medical education market is estimated to be around 25% based on the number of medical school seats. Competitors include Estacio, Unipe, and other regional private medical schools.
- Continuing Medical Education (CME): CME programs provide ongoing training and development for medical professionals. While specific market share data is less readily available, it is a growing segment, contributing to increasing revenues. Competitors include Medscape, UpToDate, and other online medical education providers.
- Digital Services: Digital services such as iClinic and PEBMED offers digital solutions to physicans and students. Revenue from this offering is rising with a continued focus on technology. Main competitors include Whitebook and Figure 1.
Market Dynamics
Industry Overview
The Brazilian private medical education market is growing due to increasing demand for healthcare professionals and limited public education capacity. Digital health solutions are also gaining traction.
Positioning
Afya is positioned as a leading player in the Brazilian private medical education market, leveraging its quality education, extensive network of campuses, and integrated digital platform. The company's strong brand reputation is a competitive advantage.
Total Addressable Market (TAM)
The TAM for medical education and related services in Brazil is estimated to be several billion USD annually, driven by the demand for trained healthcare professionals. Afya Ltd is well-positioned to capture a substantial share of this market through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Leading market position in Brazil
- Strong brand reputation
- Extensive network of campuses
- Integrated digital platform
- Experienced management team
Weaknesses
- High reliance on regulatory approvals
- Exposure to macroeconomic conditions in Brazil
- Competition from other private education providers
- Integration risks from acquisitions
Opportunities
- Further expansion in Brazil's private medical education market
- Growth in digital health solutions
- Strategic acquisitions to expand market reach
- Partnerships with hospitals and healthcare institutions
Threats
- Changes in government regulations
- Economic downturn in Brazil
- Increased competition from domestic and international players
- Technological disruption
Competitors and Market Share
Key Competitors
- YDUQ3.SA
- CRDE3.SA
- COGN3.SA
Competitive Landscape
Afya's competitive advantage lies in its focus on medical education, integrated digital platform, and strong brand. However, competitors have larger operations in other education verticals.
Major Acquisitions
iClinic
- Year: 2019
- Acquisition Price (USD millions): 46.5
- Strategic Rationale: Expanded digital health offerings.
Growth Trajectory and Initiatives
Historical Growth: Afya Ltd has demonstrated growth through organic expansion and acquisitions of medical schools and related businesses.
Future Projections: Future growth is projected to continue, driven by demand for medical education and digital health solutions in Brazil. Consult analyst reports for detailed projections.
Recent Initiatives: Recent initiatives include the expansion of its digital health platform and the acquisition of additional medical schools.
Summary
Afya Ltd. holds a strong position in the Brazilian medical education market, driven by its quality programs and digital platform. Expansion through acquisitions and focus on digital health enhances its growth potential. Regulatory risks and economic conditions in Brazil pose potential challenges. The company's strengths in medical education and growing digital presence support a positive outlook.
Similar Companies
- YDUQ3.SA
- CRDE3.SA
- COGN3.SA
Sources and Disclaimers
Data Sources:
- Company filings (SEC), Analyst reports, Market research reports.
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market data can fluctuate, and past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange NASDAQ | Headquaters Nova Lima, MG, Brazil | ||
IPO Launch date 2019-07-19 | CEO - | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees - | Website https://www.afya.com.br |
Full time employees - | Website https://www.afya.com.br | ||
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.